December 17, 2021
Video
The future of combined treatment approaches with anti-CD19 therapies for diffuse large B-cell lymphoma.
December 17, 2021
Video
Suggestions to hematologist-oncologists when talking to patients with relapsed/refractory diffuse large B-cell lymphoma about the potential benefits of CAR T-cell therapy and toxicities.
December 06, 2021
Video
Recommendations to increase the uptake of CAR T-cell therapies into clinical practice when managing patients with relapsed/refractory diffuse large B-cell lymphoma.
December 06, 2021
Video
Variables that are likely to impact the use of loncastuximab vs a combination approach with tafasitamab and lenalidomide to treat relapsed/refractory diffuse large B-cell lymphoma.
December 03, 2021
Video
An overview of the LOTIS-1 clinical trial and the rationale for the accelerated approval of loncastuximab for relapsed/refractory diffuse large B-cell lymphoma.
December 03, 2021
Video
Recommendations for managing patients with diffuse large B-cell lymphoma on tafasitamab.